Published on
Kent Knauer
Originally published in 2014. Substantially updated and clinically reviewed in 2026.
PRESENTATION
The most common presentation of anaphylaxis is the abrupt onset of hives, swelling within the airway associated with shortness of breath or wheezing, and vomiting or diarrhea. In this situation there is presenting evidence of a multisystem allergic reaction. Another potential presentation is sudden hypotension with dizziness or loss of consciousness and no other obvious system involvement—occurring, for example, after a bee sting. The diagnosis is made clinically.
Anaphylaxis may also present with acute laryngeal symptoms, bronchospasm, or cardiovascular compromise without hives or other skin findings. Recognition and intramuscular epinephrine should not be delayed while waiting for multisystem involvement or hypotension to appear.
TRIAGE PEARLS
- Anaphylaxis may progress to respiratory or cardiovascular collapse within minutes. Treat suspected anaphylaxis immediately rather than relying on a predictable period before deterioration.
- The more rapidly the symptoms occur after the offending exposure, the more severe and potentially life-threatening the reaction is.
- Of all the systemic symptoms, respiratory compromise and cardiovascular collapse are the most frequent causes of anaphylactic fatality.
- Many of the signs and symptoms are nonspecific, such as dyspnea, stridor, incontinence, collapse, confusion, wheeze, and unconsciousness.
- Helpful diagnostic symptoms and signs such as hives, itching, flushing, and angioedema can be absent or missed in up to 20% of cases.
- Anaphylaxis is underdiagnosed and undertreated.
- At triage, identify airway, breathing, or circulation abnormalities; activate the emergency response; obtain epinephrine immediately; and arrange EMS transfer when anaphylaxis is suspected in urgent care.
HISTORY PEARLS
- Check for common presenting symptoms (listed here by organ system).
- Head, eyes, ears, nose, and throat
- Facial, lip, or tongue swelling
- Metallic taste in the mouth
- Throat tightness
- Runny nose or congestion
- Watery or itchy eyes
- Respiratory
- Shortness of breath
- Noisy breathing (representing stridor or wheeze)
- Increased work of breathing
- Cardiovascular
- Chest pain
- Palpitations
- Dizziness
- Syncope
- Swelling of hands, feet, or both
- Gastrointestinal
- Diarrhea
- Cramping
- Dysphagia
- Nausea
- Vomiting
- Genitourinary: Incontinence
- Neurologic
- Headache
- Confusion
- Psychological
- Sense of impending doom
- Panic
- Skin
- Hives or rash
- Itching
- Flushing
- Inquire about a past history of anaphylaxis.
- Check for known allergies to foods, stinging insects, or medications.
- Document the suspected exposure, time of onset, progression of symptoms, and treatments already given. Ask about food, medication, insect stings, latex, immunotherapy, and exercise-associated or otherwise unexplained reactions.
- Note that a concomitant history of asthma, chronic obstructive pulmonary disease, or heart disease increases the risk of severe or fatal reactions.
- A patient taking a beta-blocker may have a more severe or treatment-refractory reaction. Do not withhold epinephrine; medication changes and any need for adjunctive glucagon should be assessed by the receiving emergency team.
- Ask about gastrointestinal or skin symptoms that may have occurred prior to the patient’s arrival.
- Determine if there has been prior treatment with diphenhydramine or other antihistamines or with an epinephrine auto-injector, either of which may alter or partially mask physical findings.
- Ask whether an epinephrine auto-injector was used, its dose, and the time administered. Record prior severe or biphasic reactions and any need for multiple epinephrine doses.
PHYSICAL EXAM PEARLS
A focused exam that includes the following factors should be done:
- Evaluate the patient’s general appearance: Are they diaphoretic, cyanotic, or incontinent? Are they moving, talking, and making sense?
- Assess the airway immediately for voice change, stridor, progressive tongue or throat swelling, and work of breathing. Call EMS and request advanced airway assistance early; an urgent care clinician should not delay transfer while attempting a procedure beyond the facility’s training and resources.
- Note any respiratory symptoms and listen for wheezing.
- Evaluate the vital signs.
- Check the skin and mucosal surfaces for hives, angioedema, flushing, and so forth, if not obvious.
- Note that most patients with anaphylaxis have some combination of urticaria, erythema, pruritus, or angioedema; their absence does not exclude the diagnosis.
- Be aware that reduced blood pressure is defined in adults and children older than 10 years as systolic pressure below 90 mm Hg or a decrease greater than 30% from baseline; in children under 10 years, a systolic pressure below 70 + 2 × age in years is a concerning threshold. Use age-appropriate norms and assess perfusion, mental status, and capillary refill.
- Remember that reduced blood pressure is not a requirement for the diagnosis of anaphylaxis or for the use of epinephrine!
- Monitor for rapid changes in voice, breathing, oxygen saturation, pulse, blood pressure, consciousness, and perfusion. A normal oxygen saturation early in the reaction does not exclude anaphylaxis.
TESTING PEARLS
There are no tests for immediate confirmation of anaphylaxis.
- Pulse oximetry is helpful for monitoring.
- Serum tryptase can support a retrospective diagnosis when an acute sample is obtained, ideally within 2 hours of symptom onset, and compared with a later baseline sample. It is not required to diagnose anaphylaxis or to decide whether to give epinephrine, and obtaining it must not delay emergency treatment or transfer.
- Continuous clinical reassessment is more important than laboratory testing during the acute episode. Consider electrocardiographic monitoring and IV access if available without delaying epinephrine or EMS.
DIAGNOSIS PEARLS
Anaphylaxis is a clinical diagnosis. The following World Allergy Organization criteria make anaphylaxis highly likely when either criterion is met:
- Acute onset of skin or mucosal symptoms (eg, generalized hives, flushing, or swelling of the lips or tongue) with at least one of the following: respiratory compromise, reduced blood pressure or associated collapse, or severe gastrointestinal symptoms such as repetitive vomiting or severe crampy abdominal pain (especially following a nonfood allergen).
- Acute onset of hypotension, bronchospasm, or laryngeal involvement after exposure to a known or highly probable allergen, even in the absence of skin findings.
Clinicians should be aware of the following facts:
- Skin or mucosal symptoms, signs, or both are present in up to 90% of cases, and respiratory symptoms occur in up to 70%.
- Hives and angioedema often present in isolation apart from anaphylaxis, but they are always a potential sign that something worse is about to happen.
- Hypotension, but not hypertension, is a common sign in severe anaphylaxis.
- Tachycardia is also frequent in systemic reactions, but bradycardia may suggest a vasovagal cause of loss of consciousness.
- Isolated hives or mild isolated gastrointestinal symptoms do not automatically establish anaphylaxis. Reassess the patient for progression, especially after a plausible trigger, and treat immediately if airway, breathing, circulation, or severe multisystem involvement develops.
- Formal diagnostic criteria assist recognition, but treatment with epinephrine should not be withheld solely because the patient has not yet met all criteria when evolving anaphylaxis is clinically suspected.
TREATMENT AND DISPOSITION PEARLS
- Activate the emergency response, summon staff and equipment, and call 911/EMS for suspected anaphylaxis with airway, breathing, or circulatory involvement in an urgent care setting. Do not delay the first dose of epinephrine while calling.
- Inject epinephrine 1 mg/mL (1:1,000) intramuscularly into the mid-outer thigh immediately: 0.01 mg/kg (0.01 mL/kg), to a maximum of 0.5 mg per dose in adults and 0.3 mg per dose in most children. An adult dose is usually 0.3–0.5 mg. Repeat every 5–15 minutes if symptoms persist or recur. Use an appropriately dosed, available auto-injector when faster or safer than drawing up medication.
- There are no absolute contraindications to the use of epinephrine in anaphylaxis.
- Giving antihistamines, steroids, or both as a first-line treatment for anaphylaxis is the most common error in the urgent care or emergency department setting.
- Epinephrine promptly reverses the physiologic abnormalities of anaphylaxis.
- Position the patient supine, with legs elevated if tolerated and hypotensive. For significant breathing difficulty, use a supported semi-recumbent position; place an unconscious, breathing patient on the side and a pregnant patient on the left side. Do not allow sudden standing or walking during an acute reaction.
- Provide supplemental oxygen for hypoxemia, respiratory distress, or severe anaphylaxis; monitor oxygen saturation and vital signs while awaiting EMS.
- Establish IV access if feasible without delaying epinephrine or transport. For hypotension or shock, give rapid isotonic crystalloid boluses (eg, 20 mL/kg in children; approximately 1–2 L initially in adults, reassessing frequently) according to patient size, perfusion, and cardiopulmonary status.
- For persistent shock or airway compromise despite repeated IM epinephrine and appropriate supportive care, expedite advanced life support and ED transfer. IV epinephrine infusion is a high-risk intervention reserved for appropriately monitored, experienced teams; routine IV bolus epinephrine is not appropriate for anaphylaxis in urgent care.
- Add aerosolized albuterol treatment for refractory bronchospasm.
- After epinephrine and stabilization, an oral second-generation H1 antihistamine may relieve residual hives or itching if the patient can swallow. Antihistamines do not treat airway obstruction or shock. Routine corticosteroids and H2 blockers are not recommended as primary anaphylaxis treatment, and antihistamines or steroids have not been shown reliably to prevent biphasic reactions.
- Administer cardiopulmonary resuscitation in the worst-case scenario.
- Arrange emergency department evaluation and risk-based observation for patients treated for active anaphylaxis in urgent care. Observation duration is individualized according to severity, hypotension, hypoxia, persistence of symptoms, prior biphasic events, and need for more than one epinephrine dose; there is no universally safe fixed observation period.
- Advise every patient with anaphylaxis of the absolute necessity of following up with an allergist.
- Ensure at discharge that the patient has obtained a prescription for an epinephrine auto-injector and understands how to use it correctly.
- Before discharge from the receiving facility, patients should have access to epinephrine, device-specific demonstration and teach-back, a written emergency action plan, trigger-avoidance counseling, and instructions for recurrence and follow-up. The need to activate EMS after community self-treatment should be individualized according to response and the patient’s care plan; ongoing, severe, recurrent, or nonresolving symptoms require emergency evaluation.
MEDICOLEGAL PEARLS
- Document the initial and repeated airway examination, including voice change, stridor, tongue or pharyngeal swelling, breath sounds, oxygenation, and signs of respiratory fatigue. Suspected progression requires immediate epinephrine and emergency airway resources.
- Do not postpone EMS transfer solely to obtain a normal airway examination. Give epinephrine promptly, support the airway and ventilation with available resources, and arrange the safest transfer to a facility with advanced airway capability.
- Patients who have exhibited significant signs of anaphylaxis should be given very strict instructions and a prescription for an epinephrine auto-injector prior to being sent home.
- It is important to document discharge instructions warning patients of the particular agents that cause them to experience atopic reactions.
- Document suspected triggers, timing and doses of epinephrine, patient response, repeated vital signs, adjunctive therapies, discussion with EMS or the emergency department, and disposition. Do not record a lack of hives or a normal initial blood pressure as evidence that anaphylaxis was excluded.
REFERENCES
- Anchor J, Settipane RA. Appropriate use of epinephrine in anaphylaxis. Am J Emerg Med. 2004;22:488-490.
- Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:S483-S523.
- Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. 2002;110:341-348.
- Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117:391-397.
- Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation. 2008;77:157-169.
- Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-176. doi:10.1016/j.anai.2023.09.015.
- Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472. doi:10.1016/j.waojou.2020.100472.
- Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and GRADE analysis. J Allergy Clin Immunol. 2020;145(4):1082-1123. doi:10.1016/j.jaci.2020.01.017.
- Wang J, Lieberman JA, Wallace DV, Waserman S, Golden DBK. Anaphylaxis in practice: a guide to the 2023 practice parameter update. J Allergy Clin Immunol Pract. 2024;12(9):2325-2336. doi:10.1016/j.jaip.2024.06.036.
- Centers for Disease Control and Prevention. Preventing and managing adverse reactions. CDC. Accessed November 5, 2026. https://www.cdc.gov/vaccines/hcp/imz-best-practices/preventing-managing-adverse-reactions.html.
- Resuscitation Council UK. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. May 2021. Accessed November 5, 2026. https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis/emergency-treatment-anaphylactic-reactions.
